221 related articles for article (PubMed ID: 27100743)
1. A critical role for topoisomerase IIb and DNA double strand breaks in transcription.
Calderwood SK
Transcription; 2016 May; 7(3):75-83. PubMed ID: 27100743
[TBL] [Abstract][Full Text] [Related]
2. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
[TBL] [Abstract][Full Text] [Related]
3. Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?
Haffner MC; De Marzo AM; Meeker AK; Nelson WG; Yegnasubramanian S
Clin Cancer Res; 2011 Jun; 17(12):3858-64. PubMed ID: 21385925
[TBL] [Abstract][Full Text] [Related]
4. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.
Ju BG; Lunyak VV; Perissi V; Garcia-Bassets I; Rose DW; Glass CK; Rosenfeld MG
Science; 2006 Jun; 312(5781):1798-802. PubMed ID: 16794079
[TBL] [Abstract][Full Text] [Related]
5. A breaking strategy for topoisomerase IIbeta/PARP-1-dependent regulated transcription.
Ju BG; Rosenfeld MG
Cell Cycle; 2006 Nov; 5(22):2557-60. PubMed ID: 17106262
[TBL] [Abstract][Full Text] [Related]
6. Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA.
Morimoto S; Tsuda M; Bunch H; Sasanuma H; Austin C; Takeda S
Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31671674
[TBL] [Abstract][Full Text] [Related]
7. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase IIβ associates with Ku70 and PARP-1 during double strand break repair of DNA in neurons.
Mandraju R; Chekuri A; Bhaskar C; Duning K; Kremerskothen J; Kondapi AK
Arch Biochem Biophys; 2011 Dec; 516(2):128-37. PubMed ID: 22019940
[TBL] [Abstract][Full Text] [Related]
9. Replication-dependent and transcription-dependent mechanisms of DNA double-strand break induction by the topoisomerase 2-targeting drug etoposide.
Tammaro M; Barr P; Ricci B; Yan H
PLoS One; 2013; 8(11):e79202. PubMed ID: 24244448
[TBL] [Abstract][Full Text] [Related]
10. The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks.
Kruhlak M; Crouch EE; Orlov M; Montaño C; Gorski SA; Nussenzweig A; Misteli T; Phair RD; Casellas R
Nature; 2007 Jun; 447(7145):730-4. PubMed ID: 17554310
[TBL] [Abstract][Full Text] [Related]
11. Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.
Ghosh R; Roy S; Kamyab J; Danzter F; Franco S
DNA Repair (Amst); 2016 Sep; 45():56-62. PubMed ID: 27373144
[TBL] [Abstract][Full Text] [Related]
12. Differential requirement for H2AX and 53BP1 in organismal development and genome maintenance in the absence of poly(ADP)ribosyl polymerase 1.
Orsburn B; Escudero B; Prakash M; Gesheva S; Liu G; Huso DL; Franco S
Mol Cell Biol; 2010 May; 30(10):2341-52. PubMed ID: 20231360
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
Bryant HE; Helleday T
Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
[TBL] [Abstract][Full Text] [Related]
15. Pausing sites of RNA polymerase II on actively transcribed genes are enriched in DNA double-stranded breaks.
Singh S; Szlachta K; Manukyan A; Raimer HM; Dinda M; Bekiranov S; Wang YH
J Biol Chem; 2020 Mar; 295(12):3990-4000. PubMed ID: 32029477
[TBL] [Abstract][Full Text] [Related]
16. Promoter cleavage: a topoIIbeta and PARP-1 collaboration.
Lis JT; Kraus WL
Cell; 2006 Jun; 125(7):1225-7. PubMed ID: 16814707
[TBL] [Abstract][Full Text] [Related]
17. Endogenous topoisomerase II-mediated DNA breaks drive thymic cancer predisposition linked to ATM deficiency.
Álvarez-Quilón A; Terrón-Bautista J; Delgado-Sainz I; Serrano-Benítez A; Romero-Granados R; Martínez-García PM; Jimeno-González S; Bernal-Lozano C; Quintero C; García-Quintanilla L; Cortés-Ledesma F
Nat Commun; 2020 Feb; 11(1):910. PubMed ID: 32060399
[TBL] [Abstract][Full Text] [Related]
18. Transcription. Gene expression needs a break to unwind before carrying on.
Haince JF; Rouleau M; Poirier GG
Science; 2006 Jun; 312(5781):1752-3. PubMed ID: 16794066
[No Abstract] [Full Text] [Related]
19. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation.
Hinz M; Stilmann M; Arslan SÇ; Khanna KK; Dittmar G; Scheidereit C
Mol Cell; 2010 Oct; 40(1):63-74. PubMed ID: 20932475
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid Receptor Transcriptional Activation via the BRG1-Dependent Recruitment of TOP2β and Ku70/86.
Trotter KW; King HA; Archer TK
Mol Cell Biol; 2015 Aug; 35(16):2799-817. PubMed ID: 26055322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
